Federal Register #2026-15297

FDA Announces Internal Reorganization and Delegation of Authority

This notice announces an internal reorganization within the Food and Drug Administration (FDA), part of the Department of Health and Human Services. - The FDA is centralizing and enhancing key agency functions to improve efficiency and reduce redundancies. - The reorganization affects divisions and branches related to procurement, scientific support, information technology, public affairs, health advancement, mission IT services, and security operations. - No products, services, OEMs, or vendors are requested or mentioned in this notice. - The announcement is focused solely on internal agency restructuring and invites public comments via regulations.gov.

Description

The Food and Drug Administration (FDA) plans to centralize and enhance key functions across the agency to reduce redundancies, improve efficiency, and advance alignment to better serve the American public. This notice announces the FDA's plan to reorganize and delegate functions within the agency to improve operational efficiency. The reorganization includes various divisions and branches within the FDA to streamline operations and enhance service delivery. Comments on the notice can be submitted via the provided regulations.gov link.

View original listing